Research never stops

Archive



Dec 10, 2008

Jörn Aldag resigns as CEO of Evotec AG

Dec 03, 2008

Evotec Announces Three-Year Drug Discovery Collaboration

Nov 14, 2008

Evotec Reports Strong Third Quarter 2008 and Improves Full-Year Guidance

Oct 30, 2008

Evotec Earns Two Milestone Payments from Boehringer Ingelheim

Oct 27, 2008

Evotec Reports Phase I Safety Data from Tyramine Interaction Study with EVT 302

Oct 09, 2008

Evotec Announces Phase I Initiation with P2X7 Antagonist

Sep 16, 2008

Evotec Participates in the Sale of Direvo Biotech to Bayer Healthcare

Sep 11, 2008

Evotec Reports Start of Phase II Proof-of-Concept Quit Rate Study with EVT 302 and Results of Craving Study

Sep 02, 2008

Evotec and Boehringer Ingelheim Achieve Milestone in Joint Discovery Collaboration

Aug 06, 2008

Evotec Reports Results of the First Half of 2008

Aug 01, 2008

Evotec Announces Initiation of Phase I Clinical Trial of VR1 Antagonist under Partnership with Pfizer Inc.

Jul 21, 2008

Dr Flemming Ornskov Nominated for Election as Chairman of the Supervisory Board of Evotec

Jul 03, 2008

Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study

May 08, 2008

Evotec Reports First Quarter 2008 Results

May 05, 2008

Evotec Completes Acquisition of Renovis

May 02, 2008

Evotec Completes Acquisition of Renovis

May 01, 2008

Renovis Stockholders Approve Acquisition by Evotec

Mar 28, 2008

Evotec's EVT 101 Shown to Penetrate the Brain in Man and to Modulate Brain Activity during the Performance of Cognitive Tasks

Mar 28, 2008

Evotec Announces Financial Results for 2007

Mar 27, 2008

Ono Enters into a New Fragment-Based Drug Discovery Agreement with Evotec

Mar 26, 2008

Evotec's Registration Statement in Connection with its Proposed Acquisition of Renovis Declared Effective

Mar 12, 2008

Spermatech Selects Evotec as Partner for High-Throughput Screening and Lead Discovery

Mar 06, 2008

Evotec Expands Collaboration with InterMune

Feb 28, 2008

Evotec Starts Phase II in Smoking Cessation with EVT 302

Feb 14, 2008

Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million

Jan 07, 2008

Phase I Safety and Tolerability Study with EVT 302 Successfully Completed

Jan 07, 2008

Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis